Advertisement

Spinal Tech

Michel Orsinger, CEO of Synthes, recently received $52 million as a result of Johnson & Johnson's acquisition of the company, if the deal closes sometime over the next two years, according to a Philadelphia Inquirer report.

Advertisement

A new study led by Art Sedrakyan, MD, of Weill Cornell Medical College in New York City, recently found that new metal-on-metal and ceramic-on-ceramic hip implants have no better outcomes than traditional polyethylene implants, according to a Weill Cornell news…

Sports medicine device company ArthroCare recently reached an agreement in principle to settle pending private securities class action suits against the company and two former officers, according to an ArthroCare news release.

Advertisement